Safety and immunogenicity of a bivalent Ebola virus and Sudan virus ChAdOx1 vectored vaccine in adults in the UK: an open-label, non-randomised, first-in-human, phase 1 clinical trial

Jenkin D., Makinson R., Sanders H., Sampson A., Platt A., Tran N., Dinesh T., Mabbett R., Lawrie A., Quaddy J., Poulton I., Berrie E., Cicconi P., Lambe T.

DOI

10.1016/j.lanmic.2024.101022

Type

Journal article

Journal

The Lancet Microbe

Publisher

Elsevier BV

Publication Date

02/2025

Pages

101022 - 101022

Permalink Original publication